title: Postoperative nausea and emesis.
abstract: Watcha and White [51] have made recommendations for antiemetic therapy and prophylaxis based on published peer-reviewed studies. They range from no prophylaxis for patients at low risk to "multimodal" antiemetic therapy for those at the highest risk (Fig. 1) [10]. Recommendations for rescue therapy of breakthrough PONV are also provided. With this approach, it should be possible [figure: see text] to individualize prophylaxis and rescue therapy to achieve an optimal cost-effective management strategy for this uncomfortable postoperative complication.
authors.affiliation: Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. watcha@email.chop.edu
authors.forename: Mehernoor F
authors.initials: MF
authors.lastname: Watcha
mesh_terms: D000777:Anesthetics / Q000009:adverse effects; D000932:Antiemetics / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D020250:Postoperative Nausea and Vomiting / Q000188:drug therapy / Q000191:economics / Q000503:physiopathology / Q000628:therapy*; D009626:Terminology as Topic
chemical_list: D000777:Anesthetics; D000932:Antiemetics